Table 3.

Geometric means for immune markers at visit 0–1 year prior to reference date among HIV-infected control women by select characteristics

	sCD23 (units/mL)	sCD27 (units/mL)	sCD30 (units/mL)	CXCL13 (pg/mL)	IL6 (pg/mL)	CRP (μg/mL)
Baseline characteristics
WIHS site
New York	49	494	115	213	2.7	3.3
DC	56	361	103	220	1.5	1.5
California	39	342	76	153	1.2	2.0
Chicago	64	406	78	198	2.0	2.3
p-value	0.338	0.075	0.052	0.230	0.044	0.470
Race/ethnicity
African-American, non- Hispanic	47	409	92	211	2.0	2.3
White, non-Hispanic	52	422	92	173	1.4	2.7
Latina/Hispanic	54	339	76	113	1.3	2.0
p-value	0.877	0.557	0.698	0.018	0.372	0.872
Education
Less than high school	59	420	97	197	1.7	1.7
High school graduate	40	409	83	194	1.9	3.1
More than high school	49	381	90	175	1.7	2.6
p-value	0.342	0.785	0.670	0.760	0.894	0.263
HCV positivea
No	49	376	87	177	1.7	3.0
Yes	49	519	103	233	2.1	1.0
p-value	0.977	0.022	0.324	0.116	0.469	0.005
Characteristics at AIDS-NHL diagnosis or reference date
Reference year
1995–2001	51	425	103	210	2.0	2.1
2002–2008	46	366	71	154	1.5	2.8
p-value	0.633	0.224	0.008	0.039	0.216	0.404
Age (years)
<30	35	397	130	241	1.8	1.9
30–39	55	399	94	196	1.9	3.1
40–49	47	433	90	177	1.5	1.6
≥50	31	322	44	141	1.7	1.8
p-value	0.427	0.683	0.016	0.502	0.896	0.318
Cigarette smokingb
Never	53	340	79	158	1.1	2.2
Current	51	504	105	208	2.2	2.1
Former	43	336	83	209	2.6	3.0
p-value	0.781	0.001	0.129	0.200	0.025	0.726
CD4+ T cells/mm3 c
<200	44	450	123	243	2.6	3.0
200–400	45	427	95	189	1.1	1.1
>400	52	354	65	142	1.5	2.4
p-value	0.731	0.171	<0.001	0.002	0.019	0.065
HIV RNA copiesd
<4000	45	299	55	128	1.2	2.2
4000–20,000	43	429	106	200	1.4	2.1
>20000	56	504	126	253	2.8	2.6
p-value	0.544	<0.001	<0.001	<0.001	0.005	0.837
Prior AIDS diagnosis
No	51	426	94	179	1.8	2.5
Yes	47	387	87	195	1.8	2.2
p-value	0.710	0.434	0.570	0.560	0.945	0.682
Prior HAART exposureb
No	50	447	110	207	2.2	2.0
Yes	48	366	75	172	1.5	2.8
p-value	0.836	0.091	0.005	0.203	0.094	0.284

^aRNA positive or antibody positive at baseline study visit

^b“No” indicates unexposed at all three serum sampling time points, “Yes” indicates exposed at least one time point